{
    "title": "107_hr1387",
    "content": "SECTION 1. SHORT TITLE; TABLE OF CONTENTS.\n\n    (a) Short Title.--This Act may be cited as the ``Drug Availability \nand Health Care Access Improvement Act of 2001''.\n    (b) Table of Contents.--The table of contents of this Act is as \nfollows:\n\nSec. 1. Short title; table of contents.\n TITLE I--MEDICAID PRESCRIPTION DRUG COVERAGE FOR LOW-INCOME MEDICARE \n                             BENEFICIARIES\n\nSec. 101. Medicaid prescription drug coverage for low-income medicare \n                            beneficiaries.\nTITLE II--IMPROVED ACCESS OF MEDICARE BENEFICIARIES TO MEDICARE+CHOICE \n                                 PLANS\n\nSec. 201. Improved access to Medicare+Choice plans through an increase \n                            in the minimum Medicare+Choice capitation \n                            rate.\n   TITLE III--IMPROVED ACCESS TO REASONABLY PRICED PRESCRIPTION DRUGS\n\nSec. 301. Amendments to program for importation of certain prescription \n                            drugs by pharmacists and wholesalers.\n\n TITLE I--MEDICAID PRESCRIPTION DRUG COVERAGE FOR LOW-INCOME MEDICARE \n                             BENEFICIARIES\n\nSEC. 101. MEDICAID PRESCRIPTION DRUG COVERAGE FOR LOW-INCOME MEDICARE \n              BENEFICIARIES.\n\n    (a) In General.--Section 1902(a)(10) of the Social Security Act (42 \nU.S.C. 1396a(a)(10)) is amended--\n            (1) by striking ``and'' at the end of subparagraph (F);\n            (2) by adding ``and'' at the end of subparagraph (G); and\n            (3) by inserting after subparagraph (G) the following new \n        subparagraph:\n                    ``(H) for making medical assistance available for \n                prescribed drugs (in the same amount, duration, and \n                scope as for individuals described in subparagraph (A)) \n                for qualified medicare beneficiaries described in \n                section 1905(p)(1) and for individuals who would be \n                such qualified medicare beneficiaries but for the fact \n                that their income exceeds the income level established \n                by the State under section 1905(p)(2) but is less than \n                175 percent of the official poverty line (referred to \n                in such section) for a family of the size involved;''.\n    (b) 100 Percent Federal Financing of Additional Costs.--Section \n1903(a) of such Act (42 U.S.C. 1396b(a)) is amended--\n            (1) by redesignating paragraph (7) as paragraph (8); and\n            (2) by adding after paragraph (6) the following new \n        paragraph:\n            ``(7) an amount equal to 100 percent of amounts as expended \n        as medical assistance for prescribed drugs described in section \n        1902(a)(10)(H) to individuals who are eligible for such \n        assistance only on the basis of such section; and''.\n    (c) Permitting Charging of Sliding Scale Premiums for Qualifying \nIndividuals With Incomes Above 135 Percent of Poverty Line.--Section \n1916 of such Act Social Security Act is amended--\n            (1) in subsection (b), by striking ``or (E)'' and inserting \n        ``, (E), or (H)''; and\n            (2) in subsection (d)--\n                    (A) by inserting ``(1)'' after ``(d)'', and\n                    (B) by adding at the end the following new \n                paragraph:\n    ``(2)(A) With respect to an individual described in section \n1902(a)(10)(H) whose income (as determined under section 1905(p)(1)(B)) \nexceeds 135 percent of the official poverty line referred to in that \nsection, the State plan of a State shall provide for the charging of a \npremium (expressed as a percentage of the average actuarial cost of the \nbenefits described in section 1902(a)(10)(H) provided with respect to \nindividuals described in such section) according to a sliding scale \nunder which such percentage increases from 0 percent to 100 percent, in \nreasonable increments (as determined by the Secretary), as the \nindividual's income increases from 135 percent of such poverty line to \n175 percent of such poverty line.\n    ``(B) A State shall not require prepayment of a premium imposed \npursuant to subparagraph (A) and shall not terminate eligibility of an \nindividual for medical assistance under this title on the basis of \nfailure to pay any such premium until such failure continues for a \nperiod of not less than 60 days. The State may waive payment of any \nsuch premium in any case where the State determines that requiring such \npayment would create an undue hardship.\n    ``(C) A State may permit State or local funds available under other \nprograms to be used for payment of a premium imposed under subparagraph \n(A). Payment of a premium with such funds shall not be counted as \nincome to the individual with respect to whom such payment is made.''.\n    (d) Effective Date.--The amendments made by this section take \neffect on the first day of the first year that begins more than 6 \nmonths after the date of the enactment of this Act.\n\nTITLE II--IMPROVED ACCESS OF MEDICARE BENEFICIARIES TO MEDICARE+CHOICE \n                                 PLANS\n\nSEC. 201. IMPROVED ACCESS TO MEDICARE+CHOICE PLANS THROUGH AN INCREASE \n              IN THE MINIMUM MEDICARE+CHOICE CAPITATION RATE.\n\n    (a) In General.--Section 1853(c)(1)(B) of the Social Security Act \n(42 U.S.C. 1395w-23(c)(1)(B)), as amended by section 601(a) of \nMedicare, Medicaid, and SCHIP Benefits Improvement and Protection Act \nof 2000 (as enacted into law by section 1(a)(6) of Public Law 106-554), \nis amended--\n            (1) by redesignating clause (iv) as clause (v);\n            (2) by inserting after clause (iii) the following new \n        clause:\n                            ``(iv) For 2002--\n                                    ``(I) for any area in the 50 States \n                                and the District of Columbia, $600; and\n                                    ``(II) for any other area, the \n                                minimum amount specified in clause \n                                (iii) for that area for 2001 increased \n                                by the national per capita \n                                Medicare+Choice growth percentage, \n                                described in paragraph (6)(A) for \n                                2002.''; and\n            (3) in clause (v), as so redesignated--\n                    (A) by striking ``2002'' and inserting ``2003''; \n                and\n                    (B) by striking ``or clause (iii)'' and inserting \n                ``or clause (iv)''.\n    (b) Effective Date.--The amendments made by subsection (a) apply to \nyears beginning with 2002.\n\n   TITLE III--IMPROVED ACCESS TO REASONABLY PRICED PRESCRIPTION DRUGS\n\nSEC. 301. AMENDMENTS TO PROGRAM FOR IMPORTATION OF CERTAIN PRESCRIPTION \n              DRUGS BY PHARMACISTS AND WHOLESALERS.\n\n    Section 804 of the Federal Food, Drug, and Cosmetic Act (as added \nby section 745(c)(2) of Public Law 106-387) is amended--\n            (1) by striking subsections (e) and (f) and inserting the \n        following subsections:\n    ``(e) Testing; Approved Labeling.--\n            ``(1) Testing.--Regulations under subsection (a)--\n                    ``(A) shall require that testing referred to in \n                paragraphs (6) through (8) of subsection (d) be \n                conducted by the importer of the covered product \n                pursuant to subsection (a), or the manufacturer of the \n                product;\n                    ``(B) shall require that, if such tests are \n                conducted by the importer, information needed to \n                authenticate the product being tested be supplied by \n                the manufacturer of such product to the importer; and\n                    ``(C) shall provide for the protection of any \n                information supplied by the manufacturer under \n                subparagraph (B) that is a trade secret or commercial \n                or financial information that is privileged or \n                confidential.\n            ``(2) Approved labeling.--For purposes of importing a \n        covered product pursuant to subsection (a), the importer \n        involved may use the labeling approved for the product under \n        section 505, notwithstanding any other provision of law.\n    ``(f) Discretion of Secretary Regarding Testing.--The Secretary may \nwaive or modify testing requirements described in subsection (d) if, \nwith respect to specific countries or specific distribution chains, the \nSecretary has entered into agreements or otherwise approved \narrangements that the Secretary determines ensure that the covered \nproducts involved are not adulterated or in violation of section \n505.'';\n            (2) by striking subsections (h) and (i) and inserting the \n        following subsections:\n    ``(h) Prohibited Agreements; Nondiscrimination.--\n            ``(1) Prohibited agreements.--No manufacturer of a covered \n        product may enter into a contract or agreement that includes a \n        provision to prevent the sale or distribution of covered \n        products imported pursuant to subsection (a).\n            ``(2) Nondiscrimination.--No manufacturer of a covered \n        product may take actions that discriminate against, or cause \n        other persons to discriminate against, United States \n        pharmacists, wholesalers, or consumers regarding the sale or \n        distribution of covered products.\n    ``(i) Study and Report.--\n            ``(1) Study.--The Comptroller General of the United States \n        shall conduct a study on the imports permitted under this \n        section, taking into consideration the information received \n        under subsection (a). In conducting such study, the Comptroller \n        General shall--\n                    ``(A) evaluate importers' compliance with \n                regulations, determine the number of shipments, if any, \n                permitted under this section that have been determined \n                to be counterfeit, misbranded, or adulterated; and\n                    ``(B) consult with the United States Trade \n                Representative and United States Patent and Trademark \n                Office to evaluate the effect of importations permitted \n                under this section on trade and patent rights under \n                Federal law.\n            ``(2) Report.--Not later than 5 years after the effective \n        date of final regulations issued pursuant to this section, the \n        Comptroller General of the United States shall prepare and \n        submit to Congress a report containing the study described in \n        paragraph (1).'';\n            (3) in subsection (k)(2)--\n                    (A) by redesignating subparagraphs (A) through (E) \n                as subparagraphs (B) through (F), respectively; and\n                    (B) by inserting before subparagraph (B) (as so \n                redesignated) the following subparagraph:\n                    ``(A) The term `discrimination' includes a contract \n                provision, a limitation on supply, or other measure \n                which has the effect of providing United States \n                pharmacists, wholesalers, or consumers access to \n                covered products on terms or conditions that are less \n                favorable than the terms or conditions provided to any \n                foreign purchaser of such products.'';\n            (4) by striking subsection (m); and\n            (5) by inserting after subsection (l) the following \n        subsection:\n    ``(m) Funding.--For the purpose of carrying out this section, there \nare authorized to be appropriated such sums as may be necessary for \nfiscal year 2002 and each subsequent fiscal year.''."
}